Monalizumab: inhibiting the novel immune checkpoint NKG2A

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Dimensions has found 143 publications that cite this research output.

Article in Current Oncology Reports (May 2023)

Article in European Journal of Immunology (May 2023)

Article in mAbs (May 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.